Commentary & Opinion

Opinion: Partnerships Under Medicines Patent Pool Key to Lowering Antiretroviral Therapy Costs

July 24, 2013

The ONE blog features an interview with Esteban Burrone, head of policy for the Medicines Patent Pool, who discusses how antiretroviral drugs used to treat HIV became less expensive over the past decade, allowing for millions more people living with the virus to receive treatment. Burrone says partnerships with pharmaceutical companies have been key in reducing the cost of treatment, and he adds, "Our focus is now on drugs under development and second- and third-line medicines, which patients need when they develop resistance" (7/23).

Back to other news for July 2013

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.